Unknown PHASE4 INTERVENTIONAL 4-arm NCT00628784

Endoesophageal Cryotherapy For Ablating Barrett's Esophagus and Early Stage Esophageal Cancer

Endoesophageal Cryotherapy: A New Technique For Ablating Barrett's Esophagus And Early Stage Esophageal Cancer

Sponsor: CSA Medical, Inc.

Interventions Endoscopic spray cryotherapy

Updated 6 times since 2017 Last updated: Jul 22, 2008 Started: Mar 31, 2007 Primary completion: Mar 31, 2010 Completion: Mar 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00628784, this PHASE4 trial focuses on Barrett's Esophagus and remains ongoing. Sponsored by CSA Medical, Inc., it has been updated 6 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CSA Medical, Inc.
Walter Reed Army Medical Center

Data source: Walter Reed Army Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Washington D.C., United States